Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis, The Journal of Immunology, vol.172, issue.6, pp.3893-904, 2004. ,
DOI : 10.4049/jimmunol.172.6.3893
Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases, The Journal of Immunology, vol.164, issue.2, pp.1117-1141, 2000. ,
DOI : 10.4049/jimmunol.164.2.1117
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm, Annals of Anatomy - Anatomischer Anzeiger, vol.192, issue.4, pp.179-93, 2010. ,
DOI : 10.1016/j.aanat.2010.06.006
Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells, Nature Medicine, vol.192, issue.3, pp.337-379, 2008. ,
DOI : 10.1038/nm1715
Multiple Sclerosis ??? The Plaque and Its Pathogenesis, New England Journal of Medicine, vol.354, issue.9, pp.942-55, 2006. ,
DOI : 10.1056/NEJMra052130
IMMUNOLOGY OF MULTIPLE SCLEROSIS, Annual Review of Immunology, vol.23, issue.1, pp.683-747, 2005. ,
DOI : 10.1146/annurev.immunol.23.021704.115707
CD28 and CTLA-4 coreceptor expression and signal transduction, Immunological Reviews, vol.11, issue.Suppl. 4, pp.12-26, 2009. ,
DOI : 10.1111/j.1600-065X.2009.00770.x
Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis, J Immunol, vol.154, pp.1481-90, 1995. ,
Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis., Journal of Clinical Investigation, vol.96, issue.5, pp.2195-203, 1995. ,
DOI : 10.1172/JCI118274
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions, Journal of Experimental Medicine, vol.182, issue.6, pp.1985-96, 1995. ,
DOI : 10.1084/jem.182.6.1985
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-??B subunits on IL-8 and Bcl-xL gene promoters, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6098-103, 2004. ,
DOI : 10.1073/pnas.0308688101
NF-??B family of transcription factors: Biochemical players of CD28 co-stimulation, Immunology Letters, vol.135, issue.1-2, pp.1-9, 2011. ,
DOI : 10.1016/j.imlet.2010.09.005
Two Waves of Nuclear Factor ??b Recruitment to Target Promoters, The Journal of Experimental Medicine, vol.16, issue.12, pp.1351-60, 2001. ,
DOI : 10.1093/emboj/17.5.1454
Interleukins 1?? and 6 but not transforming growth factor-?? are essential for the differentiation of interleukin 17???producing human T helper cells, Nature Immunology, vol.161, issue.9, pp.942-951, 2007. ,
DOI : 10.1084/jem.191.10.1777
The differentiation of human TH-17 cells requires transforming growth factor-?? and induction of the nuclear receptor ROR??t, Nature Immunology, vol.171, issue.6, pp.641-650, 2008. ,
DOI : 10.1084/jem.189.11.1735
A critical function for transforming growth factor-??, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses, Nature Immunology, vol.174, issue.6, pp.650-657, 2008. ,
DOI : 10.1084/jem.20012076
IL-21 and TGF-?? are required for differentiation of human TH17 cells, Nature, vol.282, issue.7202, pp.350-352, 2008. ,
DOI : 10.1038/nature07021
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nature Immunology, vol.178, issue.9, pp.967-74, 2007. ,
DOI : 10.1128/MCB.24.6.2385-2396.2004
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.121-128, 2001. ,
DOI : 10.1002/ana.1032
Defining the clinical course of multiple sclerosis: Results of an international survey, Neurology, vol.46, issue.4, pp.907-918, 1996. ,
DOI : 10.1212/WNL.46.4.907
Functional Disparity of Distinct CD28 Response Elements toward Mitogenic Responses, Journal of Biological Chemistry, vol.274, issue.48, pp.34369-74, 1999. ,
DOI : 10.1074/jbc.274.48.34369
A Critical Role for the RelA Subunit of Nuclear Factor ??B in Regulation of Multiple Immune-response Genes and in Fas-induced Cell Death, The Journal of Experimental Medicine, vol.159, issue.6, pp.999-1004, 1999. ,
DOI : 10.1016/S0092-8674(00)80174-9
Surface phenotype and antigenic specificity of human interleukin 17???producing T helper memory cells, Nature Immunology, vol.179, issue.6, pp.639-685, 2007. ,
DOI : 10.1038/ni1467
Phenotypic and functional features of human Th17 cells, The Journal of Experimental Medicine, vol.162, issue.8, pp.1849-61, 2007. ,
DOI : 10.1634/stemcells.2005-0008
C-C chemokine receptor 6???regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nature Immunology, vol.181, issue.5, pp.514-537, 2009. ,
DOI : 10.1002/glia.1101
The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis, Journal of Neuroimmunology, vol.243, issue.1-2, pp.1-11, 2012. ,
DOI : 10.1016/j.jneuroim.2011.11.008
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis, Scandinavian Journal of Immunology, vol.207, issue.Suppl 5, pp.1-13, 2011. ,
DOI : 10.1111/j.1365-3083.2011.02536.x
Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK, Blood, vol.113, issue.26, pp.6603-6613, 2009. ,
DOI : 10.1182/blood-2008-12-192914
Transcriptional regulation of the Th17 immune response by IKK??, The Journal of Experimental Medicine, vol.208, issue.4, pp.787-96, 2011. ,
DOI : 10.1016/j.immuni.2007.11.016
A novel association between filamin A and NF-kappaB inducing kinase couples CD28 to inhibitor of NF-kappaB kinase alpha and NF-kappaB activation, Immunol Lett, vol.36, pp.203-215, 2011. ,
CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase, International Immunology, vol.6, issue.5, pp.769-74, 1994. ,
DOI : 10.1093/intimm/6.5.769
Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling, Nature, vol.369, issue.6478, pp.327-336, 1994. ,
DOI : 10.1038/369327a0
T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif., Proceedings of the National Academy of Sciences, vol.91, issue.7, pp.2834-2842, 1994. ,
DOI : 10.1073/pnas.91.7.2834
Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential, Recent Patents on Inflammation & Allergy Drug Discovery, vol.2, issue.1, pp.1-10, 2008. ,
DOI : 10.2174/187221308783399270
T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis, Immunology, vol.2, pp.99-115, 2010. ,
NF-??B and the immune response, Oncogene, vol.159, issue.51, pp.6758-80, 2006. ,
DOI : 10.1038/nature02273
Increased CXCL8 (IL-8) expression in Multiple Sclerosis, Journal of Neuroimmunology, vol.155, issue.1-2, pp.161-71, 2004. ,
DOI : 10.1016/j.jneuroim.2004.06.008
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles, Journal of Neuroimmunology, vol.175, issue.1-2, pp.176-82, 2006. ,
DOI : 10.1016/j.jneuroim.2006.03.004
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, vol.105, issue.26, pp.9041-9047, 2008. ,
DOI : 10.1073/pnas.0802218105
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis, Brain, vol.132, issue.12, pp.3329-3370, 2009. ,
DOI : 10.1093/brain/awp289
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nature Immunology, vol.103, issue.11, pp.1133-1174, 2005. ,
DOI : 10.1038/35051100
Defining the human T helper 17 cell phenotype, Trends in Immunology, vol.33, issue.10, pp.505-517, 2012. ,
DOI : 10.1016/j.it.2012.05.004
Evidence for a cross-talk between human neutrophils and Th17 cells, Blood, vol.115, issue.2, pp.335-378, 2010. ,
DOI : 10.1182/blood-2009-04-216085
Cellular mechanisms of IL-17-induced blood-brain barrier disruption, The FASEB Journal, vol.24, issue.4, pp.1023-1057, 2010. ,
DOI : 10.1096/fj.09-141978
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis, The American Journal of Pathology, vol.172, issue.1, pp.146-55, 2008. ,
DOI : 10.2353/ajpath.2008.070690
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis, Immunology, vol.33, issue.Suppl. 3, pp.161-170, 2008. ,
DOI : 10.1111/j.1365-2567.2008.02837.x
Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion, Immunity, vol.36, issue.2, pp.201-215, 2012. ,
DOI : 10.1016/j.immuni.2011.12.013
Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis, International Immunology, vol.21, issue.12, pp.1329-1369, 2009. ,
DOI : 10.1093/intimm/dxp100
IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain, The American Journal of Pathology, vol.178, issue.2, pp.794-802, 2011. ,
DOI : 10.1016/j.ajpath.2010.10.043
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3, Nature Immunology, vol.14, issue.4, pp.331-338, 2005. ,
DOI : 10.1093/intimm/dxh165
FOXP3: Of Mice and Men, Annual Review of Immunology, vol.24, issue.1, pp.209-235, 2006. ,
DOI : 10.1146/annurev.immunol.24.021605.090547
The role of regulatory T cells in multiple sclerosis, Nature Clinical Practice Neurology, vol.180, issue.7, pp.384-98, 2008. ,
DOI : 10.1038/ncpneuro0832
T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients, PLoS ONE, vol.118, issue.1???2, p.21386, 2011. ,
DOI : 10.1371/journal.pone.0021386.g004
Forkhead Transcription Factor FOXP3 Upregulates CD25 Expression through Cooperation with RelA/NF-??B, PLoS ONE, vol.185, issue.10, p.48303, 2012. ,
DOI : 10.1371/journal.pone.0048303.s003
FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes, The Journal of Immunology, vol.181, issue.2, pp.1025-1058, 2008. ,
DOI : 10.4049/jimmunol.181.2.1025
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist, European Journal of Immunology, vol.33, issue.3, pp.626-664, 2003. ,
DOI : 10.1002/eji.200323570
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies, PLoS ONE, vol.193, issue.3, p.1708, 2008. ,
DOI : 10.1371/journal.pone.0001708.s005
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412, New England Journal of Medicine, vol.355, issue.10, pp.1018-1046, 2006. ,
DOI : 10.1056/NEJMoa063842
Phosphatidylinositol 4-Phosphate 5-Kinase ?? Activation Critically Contributes to CD28-Dependent Signaling Responses, The Journal of Immunology, vol.190, issue.10, pp.5279-86, 2013. ,
DOI : 10.4049/jimmunol.1203157
URL : https://hal.archives-ouvertes.fr/pasteur-01054187
CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer, Blood, vol.111, issue.3, pp.1464-71, 2008. ,
DOI : 10.1182/blood-2007-08-108050
The p110?? Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells, The Journal of Immunology, vol.177, issue.8, pp.5122-5130, 2006. ,
DOI : 10.4049/jimmunol.177.8.5122
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR, Proceedings of the National Academy of Sciences, vol.105, issue.22, pp.7797-802, 2008. ,
DOI : 10.1073/pnas.0800928105
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking, Nature Immunology, vol.180, issue.5, pp.513-534, 2008. ,
DOI : 10.1016/S0003-2697(02)00607-3
PI3K inhibition in inflammation: Toward tailored therapies for specific diseases, BioEssays, vol.104, issue.3, pp.185-96, 2010. ,
DOI : 10.1002/bies.200900150
Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor, Molecular Cancer Therapeutics, vol.11, issue.2, pp.317-345, 2012. ,
DOI : 10.1158/1535-7163.MCT-11-0474
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach, Drug Design, Development and Therapy, vol.6, pp.175-86, 2012. ,
DOI : 10.2147/DDDT.S8927
Autoimmune T cell responses in the central nervous system, Nature Reviews Immunology, vol.30, issue.6, pp.393-407, 2009. ,
DOI : 10.1038/nri2550